Multiple sclerosis and corpus callosum atrophy: Relationship of MRI findings to clinical data

SummaryAmong 110 patients (45 men, 65 women), aged 15 to 66, with clinical and/or biological diagnosis of multiple sclerosis (MS), severe to moderate corpus callosum (CC) atrophy was observed in 67 (60%) patients. Correlation between CC atrophy, brain atrophy, duration and severity of clinical symptoms, and high signal white matter areas, was carried out in 90 patients. Mean age was 46 years for those with severe CC atrophy, and 33 years for those without atrophy. Mean duration of the disease was 14 years in patients with severe atrophy, and 5 years in patients without atrophy. Severity of clinical symptoms is more pronounced in patients with severe CC atrophy. Numerous or large white matter high signal areas are observed in patients with severe CC atrophy on T2-weighted images. CC atrophy appears earlier than brain atrophy in the course of MS.

[1]  A. Weil A Textbook of Neuropathology , 1934, The Indian Medical Gazette.

[2]  J H Simon,et al.  Quantitative determination of MS-induced corpus callosum atrophy in vivo using MR imaging. , 1987, AJNR. American journal of neuroradiology.

[3]  R. M. H. McMinn,et al.  Gray's Anatomy , 1973 .

[4]  J H Simon,et al.  Corpus callosum and subcallosal-periventricular lesions in multiple sclerosis: detection with MR. , 1986, Radiology.

[5]  H. Gray Gray's Anatomy , 1858 .

[6]  R O Barnard,et al.  Corpus callosum in multiple sclerosis , 1974, Journal of neurology, neurosurgery, and psychiatry.

[7]  K. Davis,et al.  Wallerian degeneration: evaluation with MR imaging. , 1988, Radiology.

[8]  A J Barkovich,et al.  Anomalies of the corpus callosum: correlation with further anomalies of the brain. , 1988, AJR. American journal of roentgenology.